[1] Lotte R, Courdurié A, Gaudart A, et al. Spontaneous bacterial peritonitis: the incremental value of a fast and direct bacterial identification from ascitic fluids inoculated in blood culture bottles by MALDI-TOF MS for a better management of patients. Microorganisms, 2022, 10(6):1188. [2] Xiang S, Tan J, Tan C, et al. Establishment and validation of a non-Invasive diagnostic nomogram to identify spontaneous bacterial peritonitis in patients with decompensated cirrhosis. Front Med (Lausanne), 2022, 8:797363. [3] Li C, Su HB, Hu JH. The periscreen strip is an accurate and rapid method to diagnose spontaneous bacterial peritonitis among patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol, 2021, 33(Suppl 1):e206-e213. [4] Arroyo V, Jiménez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol, 2000, 32(1 Suppl):157-170. [5] 王菁, 毕宁, 方亮, 等. 乙型肝炎肝硬化并发自发性细菌性腹膜炎患者CD64指数及血清sTREM-1和IL-6水平变化与肠黏膜屏障功能关系研究. 实用肝脏病杂志, 2022, 25(1):79-82. [6] ELshamy RM, Oda MS, Saeed MA, et al. A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital. Eur J Gastroenterol Hepatol, 2022, 34(6):655-663. [7] Ratnasekera IU, Johnson A, Powell EE, et al. Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017: a population-based study. Medicine (Baltimore), 2022, 101(20):e29217. [8] 潘红英, 谌翠容, 尚世强, 等. 定量PCR联合基因芯片检测腹水细菌16SrRNA诊断自发性细菌性腹膜炎. 中华肝脏病杂志, 2011, 19(4):297-300. [9] Guo J, Shi J, Wang H, et al. Emerging gram-positive bacteria and drug resistance in cirrhosis patients with spontaneous bacterial peritonitis: a retrospective study. Exp Ther Med, 2019, 17(6):4568-4576. [10] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版). 中华肝脏病杂志, 2019, 27(12): 938-961. [11] Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med, 1996, 22(7):707-710. [12] 李苏萌, 刘京, 郑昕. 肝硬化合并自发性细菌性腹膜炎致病菌特征及抗菌治疗方案. 中华肝脏病杂志, 2021, 29(7):716-720. [13] Alexopoulou A, Papadopoulos N, Eliopoulos DG, et al. Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis. Liver Int, 2013, 33(7):975-981. [14] Jalan R, Fernandez J, Wiest R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol, 2014, 60(6):1310-1324. [15] Arabi YM, Dara SI, Memish Z, et al. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology, 2012, 56(6):2305-2315. [16] Jones AE, Trzeciak S, Kline JA. The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med, 2009, 37(5):1649-1654. [17] 周文杰, 张小亚, 张珺, 等. APACHEⅡ和SOFA评分联合血清降钙素原对鲍曼不动杆菌血流感染患者预后的预测价值. 中国急救医学, 2017, 37(3):221-225. [18] Wang R, Zhao J, Wei Q, et al. Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi-organ dysfunction, disease severity, and mortality in sepsis patients. J Clin Lab Anal, 2022, e24569. [19] Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology, 2002, 35(1):140-148. |